Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study)

American Journal of Cardiology

Volumn 80, Issue 5 A, 1997, Pages

  Klein, Werner ^a   Buchwald, Arnd ^a   Hillis, W Stewart ^a   Monrad, Scott ^a   Sanz, Ginés ^a   Turpie, Alexander G G ^a   Van Der Meer, Jan ^a   Olaisson, Eric ^a   Undeland, Sven ^a   Ludwig, Karin ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; SODIUM CHLORIDE;

ACUTE HEART INFARCTION; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; UNSTABLE ANGINA PECTORIS;

EID: 0030798740     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00487-6     Document Type: Conference Paper

References (11)

1. Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie AGG, van der Meer J, Olaisson E, Undeland S, Ludwig K. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Circulation. 96:1997;61-68.
2. Bratt G, Törnebohm E, Lockner D, Bergstrom K. A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment. Thromb Haemost. 53:1985;208-211.
3. Hirsh J, Levine MN. Low molecular weight heparin. J Am Soc Hematol. 79:1992;1-17.
4. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 347:1996;561-568.
5. Cohen M, Adams PC, Parry G. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation. 89:1994;81-88.
6. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 336:1990;827-830.
7. Théroux P, Ouimet H, McCans J. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 319:1988;1105-1111.
8. Théroux P, Waters D, Qiu S, McCans J, de Guise P, Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation. 88:1993;2045-2048.
9. Braunwald E, Jones RH, Mark DB. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation. 90:1994;613-622.
10. Gurfinkel EP, Manos EJ, Mejail RI, Cerda MA, Duronto EA, Garcia CN, Daroca AM, Mautner B. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol. 26:1995;313-318.
11. Kay R. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med. 333:1995;1588-1593.